22 patents protecting MedhAnkura's AI diagnostics, medical devices, pharmaceutical compositions, and digital health platforms — spanning India, US, and global filings.
Every MedhAnkura innovation is engineered with IP protection from day one.
Foundation patent for the RackIQ automated pharmacy dispensation system — covering AI-driven inventory management, dispensing automation, and consumable tracking for clinical settings.
Novel methodology for centralised blood inventory management system (BIMS) — reducing cross-match errors, donor-recipient mismatches, and wastage across hospital blood banks.
Advanced multi-parametric microbial identification platform combining AI-driven analysis for rapid sepsis pathogen detection and antibiotic susceptibility guidance.
Proprietary multi-antigen LFIA device (LabIQ platform) enabling simultaneous multi-cancer biomarker detection with AI-driven risk scoring.
Novel spirometric-AI hybrid device for longitudinal COPD control measurement — enables objective mean control assessment and compliance monitoring.
Novel oral pharmaceutical composition targeting viral sepsis through dual-mechanism mitochondrial restoration and immune modulation. Highest-value patent in the portfolio.
AI-personalised oral gel formulation system combining patient-specific microbiome profiling with adaptive gingivitis therapy.
Hardware-software integrated system for real-time formulation mixing and precision dosage delivery of personalised oral therapeutics using multi-cartridge AI dispensing.
AI-guided wound treatment device with multi-solution delivery, real-time image analytics for wound staging and healing assessment.
Computer vision and AI-driven hospital waste classification and segregation system — automating biomedical waste compliance and reducing cross-contamination risk.
Core patent for the Central Neural System (CNS) Command Centre — autonomous orchestration of healthcare operations across multi-site hub-and-spoke networks with adaptive compliance.
Automated AI validation engine for healthcare BI reporting — ensuring data integrity, detecting anomalies, and providing compliance-grade audit trails across network dashboards.
Novel post-amputation care device integrating negative pressure wound therapy and nitrogen-enriched microenvironment within a precision silicone sleeve for optimised stump healing.
AI-personalised anti-plaque formulation and delivery system using patient-specific oral microbiome mapping to optimise dental plaque prevention and treatment protocols.
Rapid narrow-band spectroscopic microbial identification system with AI-guided antibiotic susceptibility suggestions — enabling point-of-care sepsis management and antibiotic stewardship.
Novel therapeutic application of 5-ALA for viral infection treatment using mitochondrial metabolic pathway activation — companion IP to the COVID Iron-ALA therapy patent.
Hybrid PCR-AI platform for rapid sub-6-hour pathogen identification in sepsis — combining molecular diagnostics with machine learning for treatment guidance and outcome prediction.
US-filed patent covering a novel combination antiviral therapy for coronavirus infections with very low litigation risk.
US-filed combination therapy patent using Iron and 5-aminolevulinic acid for COVID and related viral infection treatment.
Wearable multi-vital continuous monitoring device with integrated AI-driven active treatment recommendations — part of the ecosystem's remote patient monitoring stack.
Advanced vector analysis of multi-channel biological and cardiac signals for continuous health monitoring and early cardiac event prediction using AI.
Platform patent covering AyuvuOS's personalised health experience engine — cumulative patient journey modelling, adaptive service delivery, and longitudinal care orchestration.